89 related articles for article (PubMed ID: 11035160)
1. Radiosensitivity of HCV cells and their v-ras and v-raf transfectants.
Kowalczyk D; Skierski J; Koronkiewicz M; Janik P
Mutat Res; 2000 Nov; 454(1-2):63-9. PubMed ID: 11035160
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants.
Przybyszewska M; Miłoszewska J; Janik P
Cancer Lett; 1998 Sep; 131(2):157-61. PubMed ID: 9851248
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenes.
Rygaard K; Slebos RJ; Spang-Thomsen M
Int J Cancer; 1991 Sep; 49(2):279-84. PubMed ID: 1652570
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29.
Skopinska-Rózewska E; Janik P; Przybyszewska M; Sommer E; Bialas-Chromiec B
Int J Mol Med; 1998 Dec; 2(6):649-52. PubMed ID: 9850731
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides in human urothelial cell lines of different transformed phenotypes: the effect of v-raf-oncogene transfection.
Ugorski M; Dus D; Skouv J; Påhlsson P; Radzikowski C
Anticancer Res; 1989; 9(6):1583-6. PubMed ID: 2627112
[TBL] [Abstract][Full Text] [Related]
7. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester and bryostatin differentially regulate the hydrolysis of phosphatidylethanolamine in Ha-ras- and raf-oncogene-transformed NIH 3T3 cells.
Kiss Z; Rapp UR; Pettit GR; Anderson WB
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):505-9. PubMed ID: 2049075
[TBL] [Abstract][Full Text] [Related]
9. A novel human ERK phosphatase regulates H-ras and v-raf signal transduction.
Shin DY; Ishibashi T; Choi TS; Chung E; Chung IY; Aaronson SA; Bottaro DP
Oncogene; 1997 Jun; 14(22):2633-9. PubMed ID: 9178761
[TBL] [Abstract][Full Text] [Related]
10. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
11. Growth factor ligands of tyrosine kinase receptors activate the Rous sarcoma virus promoter by a Ras- and Raf-dependent mechanism.
Cosgaya JM; Perez-Juste G; Castillo AI; Aranda A
Gene; 1997 Apr; 188(2):291-3. PubMed ID: 9133605
[TBL] [Abstract][Full Text] [Related]
12. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX.
Natoli G; Avantaggiati ML; Chirillo P; Puri PL; Ianni A; Balsano C; Levrero M
Oncogene; 1994 Oct; 9(10):2837-43. PubMed ID: 8084589
[TBL] [Abstract][Full Text] [Related]
13. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
Cosgaya JM; Aranda A
Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
[TBL] [Abstract][Full Text] [Related]
14. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
[TBL] [Abstract][Full Text] [Related]
15. The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.
Pomp J; Ouwerkerk IJ; Hermans J; Wondergem J; Cornelisse CJ; Leer JW; Schrier PI
Radiat Res; 1996 Oct; 146(4):374-81. PubMed ID: 8927709
[TBL] [Abstract][Full Text] [Related]
16. Radioresistance induced in rat embryo cells by transfection with the oncogenes H-ras plus v-myc is cell cycle dependent and maximal during S and G2.
Cheong N; Wang Y; Iliakis G
Int J Radiat Biol; 1993 May; 63(5):623-9. PubMed ID: 8099108
[TBL] [Abstract][Full Text] [Related]
17. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
18. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
19. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of MSX-2 homeoprotein in v-ras-induced transformation.
Takahashi C; Akiyama N; Kitayama H; Takai S; Noda M
Leukemia; 1997 Apr; 11 Suppl 3():340-3. PubMed ID: 9209384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
